| Suchada Kwunyeun Shu, MD | |
|
25825 Vermont Ave, Harbor City, CA 90710-3518 | |
| (310) 325-5111 | |
| (310) 517-4077 |
| Full Name | Suchada Kwunyeun Shu |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 25 Years |
| Location | 25825 Vermont Ave, Harbor City, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538236344 | NPI | - | NPPES |
| 00A792800 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | A79280 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
Among men who had undergone radical prostatectomy, daily consumption of a beverage powder supplement containing soy protein isolate for 2 years did not reduce or delay development of biochemical recurrence of prostate cancer compared to men who received placebo, according to a study in the July 10 issue of JAMA.
Zelos Therapeutics, Inc. has initiated patient dosing in a single dose study of three proprietary subcutaneous formulations of ZT-034 (hPTH (1-34), teriparatide). ZT-034 is being developed to compete with Eli Lilly and Company's Forteo (teriparatide [rDNA origin]) in its existing market of approximately $800M in annual sales in 2008 for the treatment of osteoporosis.
Greater Georgia Life Insurance Company is pleased to introduce Productivity Solutions – an innovative program that integrates health care programs with short-term disability programs for employer groups with 51 or more employees. Productivity Solutions leverages all of the integration points across health, absence and disability management programs to help improve employee health and productivity, as well as the organization's bottom-line.
eBioscience Corporation today announced that it has acquired privately held immunoassay technology pioneer Bender MedSystems GmbH in an all cash transaction. The acquisition will provide eBioscience with over 1,000 high profile immunology and oncology products including the Instant ELISA® and FlowCytomix(TM) brands that target the life sciences and diagnostics markets.
› Verified 2 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
Among men who had undergone radical prostatectomy, daily consumption of a beverage powder supplement containing soy protein isolate for 2 years did not reduce or delay development of biochemical recurrence of prostate cancer compared to men who received placebo, according to a study in the July 10 issue of JAMA.
Zelos Therapeutics, Inc. has initiated patient dosing in a single dose study of three proprietary subcutaneous formulations of ZT-034 (hPTH (1-34), teriparatide). ZT-034 is being developed to compete with Eli Lilly and Company's Forteo (teriparatide [rDNA origin]) in its existing market of approximately $800M in annual sales in 2008 for the treatment of osteoporosis.
Greater Georgia Life Insurance Company is pleased to introduce Productivity Solutions – an innovative program that integrates health care programs with short-term disability programs for employer groups with 51 or more employees. Productivity Solutions leverages all of the integration points across health, absence and disability management programs to help improve employee health and productivity, as well as the organization's bottom-line.
eBioscience Corporation today announced that it has acquired privately held immunoassay technology pioneer Bender MedSystems GmbH in an all cash transaction. The acquisition will provide eBioscience with over 1,000 high profile immunology and oncology products including the Instant ELISA® and FlowCytomix(TM) brands that target the life sciences and diagnostics markets.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Suchada Kwunyeun Shu, MD 393 E Walnut St, 3rd Floor Phr Systems, Pasadena, CA 91188-0001 Ph: (888) 505-0043 | Suchada Kwunyeun Shu, MD 25825 Vermont Ave, Harbor City, CA 90710-3518 Ph: (310) 325-5111 |
News Archive
Among men who had undergone radical prostatectomy, daily consumption of a beverage powder supplement containing soy protein isolate for 2 years did not reduce or delay development of biochemical recurrence of prostate cancer compared to men who received placebo, according to a study in the July 10 issue of JAMA.
Zelos Therapeutics, Inc. has initiated patient dosing in a single dose study of three proprietary subcutaneous formulations of ZT-034 (hPTH (1-34), teriparatide). ZT-034 is being developed to compete with Eli Lilly and Company's Forteo (teriparatide [rDNA origin]) in its existing market of approximately $800M in annual sales in 2008 for the treatment of osteoporosis.
Greater Georgia Life Insurance Company is pleased to introduce Productivity Solutions – an innovative program that integrates health care programs with short-term disability programs for employer groups with 51 or more employees. Productivity Solutions leverages all of the integration points across health, absence and disability management programs to help improve employee health and productivity, as well as the organization's bottom-line.
eBioscience Corporation today announced that it has acquired privately held immunoassay technology pioneer Bender MedSystems GmbH in an all cash transaction. The acquisition will provide eBioscience with over 1,000 high profile immunology and oncology products including the Instant ELISA® and FlowCytomix(TM) brands that target the life sciences and diagnostics markets.
› Verified 2 days ago
Randel R. King, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Ryokei K. Imai, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Jennifer Wing-yun Lam, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Jeffrey L. Wang, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Dr. Lawrence R Tom, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 424-251-7140 | |
Howard K. Baik, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Morgan Y. Chen, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 |